
F-Prime Capital
Description
F-Prime Capital is a prominent global venture capital firm with a distinctive dual focus on healthcare and technology sectors. As an affiliate of Fidelity Investments, the firm benefits from deep financial roots and a long-term investment horizon, allowing it to provide patient capital and strategic support to its portfolio companies. Headquartered in Cambridge, Massachusetts, F-Prime has established itself as a significant player in the venture ecosystem, known for its rigorous due diligence and hands-on approach.
The firm's investment strategy spans various stages, from seed to growth, with a particular emphasis on leading or co-leading early-stage rounds, including Seed, Series A, and Series B financings. Within healthcare, F-Prime targets innovative companies in biotech, medtech, and digital health, seeking to back breakthroughs that can transform patient care. In the technology realm, their interests lie in fintech, enterprise technology, and cybersecurity, identifying disruptive solutions that address critical business needs. Their global footprint allows them to source opportunities and support companies across different geographies.
F-Prime Capital is well-capitalized, having recently closed substantial funds to fuel its investment activities. In 2021, the firm announced the closing of a $500 million healthcare fund, followed by a $500 million technology fund in 2022, demonstrating significant capital deployment capacity. For typical first checks, F-Prime's initial investments generally range from approximately $2 million for seed-stage companies to $25 million or more for leading Series A or B rounds, reflecting their commitment to providing meaningful capital to accelerate growth. The firm boasts a strong track record, having invested in over 200 companies, leading to more than 50 IPOs and M&A events, underscoring their success in identifying and nurturing high-potential ventures. This strategic approach, combined with their extensive network and operational expertise, positions F-Prime Capital as a valuable partner for entrepreneurs aiming to build category-defining companies in their specialized domains.
Investor Profile
F-Prime Capital has backed more than 438 startups, with 33 new investments in the last 12 months alone. The firm has led 102 rounds, about 23% of its total and boasts 94 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, China.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 6 rounds in the past year.
- Typical check size: $2M – $25M.
Stage Focus
- Series A (33%)
- Series B (28%)
- Series C (13%)
- Seed (9%)
- Series Unknown (8%)
- Series D (5%)
- Series E (1%)
Country Focus
- United States (79%)
- United Kingdom (6%)
- China (5%)
- India (3%)
- Japan (2%)
- Switzerland (1%)
- Chile (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Software
- Pharmaceutical
- Medical Device
- Fintech
- Financial Services
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.